Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ISRCTN10942256) titled 'Can a multivitamin supplement reduce menopausal symptoms and improve brain function during perimenopause?' on July 9.
Study Type: Interventional
Study Design:
Allocation: N/A: single arm study
Masking: Open (masking not used)
Control: Uncontrolled
Assignment: Single
Purpose: Treatment
Primary Sponsor: University of East Anglia
Condition:
Menopause
Other
Intervention:
The participant receives Vitals+, a commercially available multivitamin supplement (Heights, Braincare Limited, London), at a dose of two capsules per day for 12 weeks. The supplement contains 12 vitamins (thiamine/B1, riboflavin/B2, niacin/B3,...